CNP and metabolic dysfunction-associated steatohepatitis: Herein, we utilized a unique mouse model with global, inducible deletion of CNP (23) to study the effects of CNP deficiency in the progression of MASH, hepatic fibrosis, and portal hypertension using two etiologically distinct experimental models.